Assignee
METABOLEX INC
US·31 granted patents·26 pending applications·465 citations·filing 1995–2013
Top patents by PatentIndex Score
57 records- 0196US7638541B25-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidineMETABOLEX INC·Filed 2007·Granted Dec 29, 2009·43 cites·2 claims
- 0295US6613802B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 2, 2003·98 cites·6 claims
- 0393US8476308B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Jul 2, 2013·12 cites·6 claims
- 0493US7432394B2Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2006·Granted Oct 7, 2008·12 cites·21 claims
- 0591US6646004B1Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2000·Granted Nov 11, 2003·40 cites·17 claims
- 0690US7714131B2Process for the stereoselective preparation of (−)-halofenate and derivatives thereofMETABOLEX INC·Filed 2006·Granted May 11, 2010·9 cites·16 claims
- 0789US6624194B1Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2000·Granted Sep 23, 2003·38 cites·17 claims
- 0888US7199259B2Resolution of α-(phenoxy)phenylacetic acid derivativesMETABOLEX INC·Filed 2003·Granted Apr 3, 2007·16 cites·18 claims
- 0987US7053180B2Isolated islet beta-cell two-pore domain potassium channelMETABOLEX INC·Filed 2003·Granted May 30, 2006·15 cites·1 claims
- 1086US6020200AEncapsulation compositions and methodsMETABOLEX INC·Filed 1996·Granted Feb 1, 2000·60 cites·3 claims
- 1184US8598374B2GPR120 receptor agonists and uses thereofMETABOLEX INC·Filed 2012·Granted Dec 3, 2013·6 cites·9 claims
- 1282US7323480B2Substituted triazoles as modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Jan 29, 2008·6 cites·21 claims
- 1381US7087394B2Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRPMETABOLEX INC·Filed 2004·Granted Aug 8, 2006·18 cites·9 claims
- 1480US7576131B2Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemiaMETABOLEX INC·Filed 2003·Granted Aug 18, 2009·12 cites·21 claims
- 1579US7622491B2Modulators of PPAR and methods of their preparationMETABOLEX INC·Filed 2005·Granted Nov 24, 2009·4 cites·57 claims
- 1679US7371888B2α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agentsMETABOLEX INC·Filed 2005·Granted May 13, 2008·3 cites·10 claims
- 1779US7344844B2Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2006·Granted Mar 18, 2008·1 cites·7 claims
- 1877US7405289B2Pancreatic islet transcription factor and uses thereofMETABOLEX INC·Filed 2003·Granted Jul 29, 2008·4 cites·16 claims
- 1976US7144985B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2002·Granted Dec 5, 2006·3 cites·10 claims
- 2072US7642358B2Substituted phenylacetic acidsMETABOLEX INC·Filed 2006·Granted Jan 5, 2010·1 cites·24 claims
- 2170US7510851B2Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemiaMETABOLEX INC·Filed 2002·Granted Mar 31, 2009·5 cites·20 claims
- 2270US7078421B2Substituted phenylacetic acidsMETABOLEX INC·Filed 2003·Granted Jul 18, 2006·4 cites·31 claims
- 2369US8354448B2Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetesMETABOLEX INC·Filed 2009·Granted Jan 15, 2013·0 cites·14 claims
- 2469US7109021B2Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2004·Granted Sep 19, 2006·1 cites·5 claims
- 2568USRE40624ECompositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2007·Granted Jan 20, 2009·0 cites·5 claims
- 2667US5916790AEncapsulation compositions, and methodsMETABOLEX INC·Filed 1995·Granted Jun 29, 1999·25 cites·39 claims
- 2765US2008318312A1Pancreatic islet transcription factor and uses thereofMETABOLEX INC·Filed 2008·Application pending·0 cites
- 2863US7556930B2CD39L3 and its role in diabetesMETABOLEX INC·Filed 2006·Granted Jul 7, 2009·2 cites·6 claims
- 2963US2010152295A1Methods of reducing small, dense ldl particlesMETABOLEX INC·Filed 2009·Application pending·0 cites
- 3062US7294698B2Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2006·Granted Nov 13, 2007·0 cites·1 claims
- 3162US2007270490A1Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2007·Application pending·0 cites
- 3261US2014128439A1Methods for Treating Gout FlaresMETABOLEX INC·Filed 2013·Application pending·0 cites
- 3360US5738876AMethod of solution overcoating with gelling polymerMETABOLEX INC·Filed 1996·Granted Apr 14, 1998·27 cites·15 claims
- 3460US2008248010A1Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)METABOLEX INC·Filed 2008·Application pending·0 cites
- 3559US2010087468A1Modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2009·Application pending·0 cites
- 3658US2009093650A1Resolution of alpha-(phenoxy)phenylacetic acid derivatives with naphthyl-alkylaminesMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3757US8912356B2DCC mediated coupling for halofenate manufactureMETABOLEX INC·Filed 2013·Granted Dec 16, 2014·0 cites·20 claims
- 3857US2008287441A1Alpha-(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agentsMETABOLEX INC·Filed 2008·Application pending·0 cites
- 3956US7491533B2Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channelMETABOLEX INC·Filed 2006·Granted Feb 17, 2009·0 cites·5 claims
- 4056US2014121246A1Gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2013·Application pending·0 cites
- 4156US2005075396A1Use of (-)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes and hyperlipidemiaMETABOLEX INC·Filed 2003·Application pending·0 cites
- 4254US2008108630A1Substituted triazoles as modulators of ppar and methods of their preparationMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4354US2007203243A1Resolution of alpha-(phenoxy) phenylacetic acid derivativesMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4452US2010216827A1Aryl gpr120 receptor agonists and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 4551US2009270404A1Oxymethylene aryl compounds and uses thereofMETABOLEX INC·Filed 2009·Application pending·0 cites
- 4651US2007031897A1Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRPMETABOLEX INC·Filed 2006·Application pending·0 cites
- 4749US2004002114A1Nucleic acids encoding a G-protein coupled receptor involved in islet cell signalingMETABOLEX INC·Filed 2003·Application pending·0 cites
- 4849US2008064857A1Methods and Reagents for Diagnosis and Treatment of DiabetesMETABOLEX INC·Filed 2007·Application pending·0 cites
- 4947US2005208516A1Methods and reagents for diagnosis and treatment of diabetesMETABOLEX INC·Filed 2004·Application pending·0 cites
- 5044US2006074018A1Methods of diagnosing & treating diabetes and insulin resistanceMETABOLEX INC·Filed 2003·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when METABOLEX INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →